Business / Finance

RSS

Emdeon expands healthcare payment integrity solutions with TC3 acquisition

Emdeon Inc., a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced its acquisition of TC3Health, Inc. The acquisition of TC3 expands Emdeon's already robust Payment Integrity solutions for healthcare payers to include new claims analytics tools from pre-adjudication through post-payment, as well as access to a broad out-of-network claims cost management solution.

7 May 2012

Keryx, Aeterna Zentaris execute perifosine license termination and technology transfer agreement

Keryx Biopharmaceuticals, Inc. today announced that the Company and Aeterna Zentaris Inc. have executed a License Termination and Technology Transfer Agreement, whereby the KRX-0401 (perifosine) license agreement has been terminated and all license rights have reverted back to Aeterna Zentaris.

7 May 2012

Unigene first quarter net loss decreases to $6.0 million

Unigene Laboratories, Inc., today announced financial results for the first quarter ended March 31, 2012.

7 May 2012

Walgreens acquires certain assets of BioScrip

Walgreen Co. today announced that it has completed its acquisition of certain assets of BioScrip, Inc.'s community specialty pharmacies and centralized specialty and mail service pharmacy businesses.

7 May 2012

ADVENTRX first quarter net loss increases to $4.2M

ADVENTRX Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2012.

7 May 2012

Kerberos to put Rinspiration Thrombectomy System up for bid

Co-Founders of Kerberos Proximal Solutions, Inc., announced today that, during the upcoming Paris Course on Revascularization, they plan to actively engage in discussions to put the company's proprietary Rinspiration technology platform up for bid, seeking buyers with complementary portfolios and distribution channels.

7 May 2012

Flamel first quarter total revenues increase to $7.3 million

Flamel Technologies today announced its financial results for the first quarter of 2012.

7 May 2012

BioCryst first quarter revenues increase to $12.2 million

BioCryst Pharmaceuticals, Inc. announced financial results for the first quarter ended March 31, 2012.

7 May 2012

Accellent to sell Pittsburgh facility to Perryman

Accellent Inc., a wholly-owned subsidiary of Accellent Holdings Corp., has entered into an agreement to sell its facility located just outside of Pittsburgh in Houston, Pennsylvania to The Perryman Company, also headquartered in Houston, Pennsylvania. Substantially all of the Facility's employees will become employees of Perryman effective upon completion of the sale, which is expected to be completed during the second quarter of 2012.

5 May 2012

ViSalus first quarter 2012 sales increase to $136.7 million

ViSalus, the number one challenge marketing company with its Body by Vi 90-Day Challenge, today announced first quarter 2012 sales of $136.7 million compared to $20.0 million for the same period last year. The Company had over 92,000 independent Promoters at the end of the first quarter versus over 16,000 for the same period last year.

5 May 2012

Pro-Dex third quarter sales decrease 34% to $4.5 million

PRO-DEX, INC. today announced financial results for its fiscal third quarter and nine months ended March 31, 2012.

5 May 2012

American Anesthesiology acquires BAA

American Anesthesiology, a division of MEDNAX, Inc., today announced the acquisition of Brazos Anesthesiology Associates, P.A. (BAA), a physician group practice based in Bryan, Texas that provides anesthesia services, including cardiac, pediatric, obstetric, regional anesthesia and chronic pain management, throughout the Brazos Valley.

5 May 2012

MAP Pharmaceuticals first quarter net loss increases to $17.8 million

MAP Pharmaceuticals, Inc. today announced financial results for the first quarter ended March 31, 2012.

5 May 2012

Oxford closes term loan securitization transaction

Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a term loan securitization transaction completed on April 26, 2012.

5 May 2012

Sirona second quarter revenue increases 8% to $231.9 million

Sirona, the dental technology leader, today announced its financial results for the quarter ended March 31, 2012.

5 May 2012

Cambrex first quarter sales increase 14.4% to $70.6 million

Cambrex Corporation reports first quarter results for the period ended March 31, 2012.

4 May 2012

NPS first quarter net loss increases to $10.6 million

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today reported its results for the first quarter of 2012.

4 May 2012

Alnylam first quarter revenues decrease to $20.6 million

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter 2012, and company highlights.

4 May 2012

NHC first quarter net income decreases 36.5% to $10,508,000

National HealthCare Corporation, a publicly traded long-term health care company, today announced net income available to common shareholders for the quarter ended March 31, 2012 of $10,508,000 compared to $16,556,000 for the quarter ended March 31, 2011, a decrease of 36.5%.

4 May 2012

Affymetrix total revenue decreases to $65.2 million

Affymetrix, Inc., today reported its operating results for the first quarter of 2012. Total revenue for the quarter was $65.2 million, as compared to total revenue of $73.7 million for the same period of 2011.

4 May 2012